Twist Bioscience SVP Dennis Cho sells $57,590 in company stock
Twist Bioscience SVP Dennis Cho sold 348 shares of the company's common stock on September 21, 2026, for a total of $57,590. This transaction was made to cover tax withholding obligations related to the vesting of Restricted Stock Units, as required by the company's equity incentive plans. Following the sale, Mr. Cho still holds 73,303 shares of Twist Bioscience common stock.
Additionally, the company has entered into a collaboration with Lilly TuneLab to provide antibody characterization data services, aiming to accelerate biotech innovation through AI/ML drug discovery. The company has also filed a prospectus supplement for the resale of shares issuable to Invenra Inc. Analyst opinions on Twist Bioscience are mixed, with some rating the stock as a sell due to competitive pressures, while others maintain a buy rating, highlighting the potential in AI-enabled drug discovery.
Brief written by urgent.news from Investing.com's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
